{"name":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","slug":"shandong-luoxin-pharmaceutical-group-stock-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amoxicilli","genericName":"Amoxicilli","slug":"amoxicilli","indication":"Acute bacterial sinusitis","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"LXI-15028","genericName":"LXI-15028","slug":"lxi-15028","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Amoxicilli","genericName":"Amoxicilli","slug":"amoxicilli","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C","indications":["Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute otitis media","Bacterial pneumonia","Bacterial urinary infection"],"catalyst":""},{"name":"LXI-15028","genericName":"LXI-15028","slug":"lxi-15028","phase":"phase_3","mechanism":"LXI-15028 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNQks3VU5ydkw4LUNZbDZUNnpUNEx2NDN4SE9mS1p2QUlHcUdZaFQ3WWxfZDZlclRTcjBiaV9uNFBlV1JQWDNGcHRiRE5kb0pLUWRLQVVFU3hmVXo2UnZFTU9TempWQTBmWlVXcWlPS3NBZnJEeDV2VThHX0JBbENKYldxbFR1cndvbUdGYnIxdTZDNjFTRUE?oc=5","date":"2026-01-02","type":"deal","source":"VCCircle","summary":"Aurobindo Pharma to buy non-oncological business of Khandelwal Labs - VCCircle","headline":"Aurobindo Pharma to buy non-oncological business of Khandelwal Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPYVYyaE9qQlFhNnpXTnU1RkNXbWNpWHEtbEhvYU5zeDdSU2pqdFR3aVJhLUp1M2YyQlAwWHRGd24yaGZvbzVxM1Z5UjYyNmtxa3VBWjh6RGlrX3JSbTZwbzJycjRnY0xoV1hpdFZlNnFkbjFxbEFmbTFuUnNEdFVpRHZ2cG1WN0V5eVk3V1ZTR1hTTmJWMG9JTVREVDQ0dXRzbjZQTmd2elFCUzBlSHNDc2tteUFmWUZMeHNwVTNvakJBeTA2RU5OaC02REdmSExEYWVN?oc=5","date":"2025-12-24","type":"deal","source":"Investment Guru","summary":"Aurobindo Pharma gains as its arm to acquire 20% additional ownership in Luoxin Aurovitas - Investment Guru","headline":"Aurobindo Pharma gains as its arm to acquire 20% additional ownership in Luoxin Aurovitas","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"deal","source":"Medical Dialogues","summary":"Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore - Medical Dialogues","headline":"Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNaWdkQzB3bXVJRE13RXVsbE4tUFYwR2pGeXdYZGxUdlpaVVpyZVM3V2wwTUM4VWlnTXJQQ1EtSl83WXFheU5aOFRQZG55MWtTNEI3Mm1KY2J6Nlp1SDROOV8zNVBNdFpGbWJDTGhXU1poeUtJY2lRaXpIeGI0OGVWRzJUWi1SS1djVldia3BqVG1QMjJ1MldmNGYxN1hwcWZ4SDd3ZEdtSDhRSEZNbllaY2dBeUZHRS1hU2xtSg?oc=5","date":"2025-12-23","type":"deal","source":"India Infoline","summary":"Aurobindo Pharma Raises Luoxin Aurovitas Stake to 50% With $5.12 Million Deal - India Infoline","headline":"Aurobindo Pharma Raises Luoxin Aurovitas Stake to 50% With $5.12 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNbUdzcTZiWThRX2o0TVlYOHhpT0d1bFBncHMzeGxEWXhPa1o5Yks3N0hrcFNOZUVHVk5MSGVIeXVkWmpQZ21YMTl2V0RVNXA1WDFxTERSSWRTVlM1OFp3UVllbWh2WDlqMlUydHFMOW9Za1hhVi1UOU1IWmNtWWdDalUzbE9YOUw1alRMZlo5S2xvMkM2LUxldw?oc=5","date":"2025-12-23","type":"deal","source":"HDFC Sky","summary":"Aurobindo Pharma Subsidiary Buys 20% More in China JV - HDFC Sky","headline":"Aurobindo Pharma Subsidiary Buys 20% More in China JV","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"deal","source":"CNBC TV18","summary":"Aurobindo Pharma arm to buy additional 20% stake in China JV for $5.1 million - CNBC TV18","headline":"Aurobindo Pharma arm to buy additional 20% stake in China JV for $5.1 million - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"deal","source":"The Economic Times","summary":"Aurobindo arm to acquire additional 20% stake in JV firm - The Economic Times","headline":"Aurobindo arm to acquire additional 20% stake in JV firm","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"pipeline","source":"BusinessLine","summary":"Aurobindo arm ups stake JV with Chinese firm - BusinessLine","headline":"Aurobindo arm ups stake JV with Chinese firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQdG0wMjFORjRUcGcteXBnZzNuMlBsTEVjSndjc0IwZDg0cGhtaWlHQjRMWGdwa0lDWHpCeW54NGxsdXVOSTJzbzJPV1VUUDUyUzBlOVlPcnduODJMSDRfQVZpa1Y2RUFhNlZQUENIeFZZdnRXS2IyMk4wekZ4bmRKR2FEMG5ZSWxnekFGbURkQnF2ajFkSmlvRldIbmJ3T1BWUlRkZ3pqZw?oc=5","date":"2025-12-23","type":"pipeline","source":"VCCircle","summary":"FirstCry parent inks M&A; Aurobindo Pharma, Info Edge to up stake in existing bets - VCCircle","headline":"FirstCry parent inks M&A; Aurobindo Pharma, Info Edge to up stake in existing bets","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-12-11","type":"pipeline","source":"The Hindu","summary":"Aurobindo Pharma arm, Luoxin to form JV in China - The Hindu","headline":"Aurobindo Pharma arm, Luoxin to form JV in China","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}